The short-term effect of atorvastatin on flow-mediated vasodilation, pulse wave velocity and carotid intima-media thickness in patients with moderate cholesterolemia

Korean Circulation Journal

Volumn 38, Issue 3, 2008, Pages 144-151

  Lee, Young Soo ^a   Kim, Kee Sik ^a  

^a Catholic University of Daegu   (South Korea)

Author keywords

Atherosclerosis; Hydroxymethylglutaryl coenzyme A reductase inhibitors

Indexed keywords

ATORVASTATIN; C REACTIVE PROTEIN; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; BIOAVAILABILITY; BRACHIAL ARTERY; CAROTID ARTERY; CAROTID ARTERY PULSE; CHOLESTEROL BLOOD LEVEL; COMMON CAROTID ARTERY; CORONARY ARTERY DILATATION; DOSE RESPONSE; DRUG EFFECT; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; PULSE WAVE; RADIAL ARTERY; TREATMENT DURATION;

EID: 47149096753     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2008.38.3.144     Document Type: Article

References (29)

1. Lüscher TF, Barton M. Biology of the endothelium. Clin Cardiol 1997;20 (Suppl II ):II3-10.
2. Simon A, Gariepy J, Chironi G, Megnien JL, Levenson J. Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk. J Hypertens 2002;20:159-69.
3. Lee YS, Kim SK, Nam CW, et al. Clinical implication of carotid-radial pulse wave velocity for patients with coronary artery disease. Korean Circ J 2006;36:565-72.
4. O'Rourke MF, Mancia G. Arterial stiffness. J Hypertens 1999;17:1-4.
5. Park KR, Kim KY, Yoon SM, Bae JH, Seong IW. Correlation between intima-media thickness in carotid artery and the extent of coronary atherosclerosis. Korean Circ J 2003;33:401-8.
6. Ray KK, Cannon CP. Intensive statin therapy in acute coronary syndromes: clinical benefits and vascular biology. Curr Opin Lipidol 2004;15:637-43.
7. Inoue I, Goto S, Mizotani K, et al. Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect: reduction of MRNA levels for interleukin-1β, interleukin-6, cyclooxygenase -2, and p22phox by regulation of peroxisome proliferator-activated receptor (PPARα) in primary endothelial cells. Life Sci 2000;67:863-76. (Pubitemid 30491080)
8. Laufs U, Wassmann S, Hilgers S, Ribaudo N, Bohm M, Nickenig G. Rapid effects on vascular function after initiation and withdrawal of atorvastatin in healthy, normocholesterolemic men. Am J Cardiol 2001;88:1306-7.
9. Taneva E, Borucki K, Wiens L, et al. Early effects on endothelial function of atorvastatin 40 mg twice daily and its withdrawal. Am J Cardiol 2006;97:1002-6.
10. Lee YS, Kim KS, Hyun DW, et al. The change of arterial stiffness according to dialysis in patients with end-stage renal disease. Korean Circ J 2004;34:865-73.
11. Kablak-Ziembicka A, Tracz W, Przewlocki T, Pieniazek P, Sokolowski A, Konieczynska M. Association of increased carotid intima-media thickness with the extent of coronary artery disease. Heart 2004;90:1286-90.
12. Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002;39:257-65.
13. Edwards JE, Moore RA. Statins in hypercholesterolaemia: a dose-specific meta-analysis of lipid changes in randomised, double blind trials. BMC Fam Pract 2003;4:18.
14. Saito Y, Goto Y, Dane A, Strutt K, Raza A. Randomized doseresponse study of rosuvasatin in Japanese patients with hypercholesterolemia. J Atheroscler Thromb 2003;10:329-36.
15. Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004;350:1495-504.
16. de Lemos JA, Blazing MA, Wiviott SD, et al. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. JAMA 2004;292:1307-16.
17. Tsunekawa T, Hayashi T, Kano H, et al. Cerivastatin, a hydroxymethylglutaryl coenzyme a reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 days. Circulation 2001;104:376-9.
18. John S, Schneider MP, Delles C, Jacobi J, Schmieder RE. Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients. Am Heart J 2005;149:473.
19. Omori H, Nagashima H, Tsurumi Y, et al. Direct in vivo evidence of a vascular statin: a single dose cerivastatin increases vascular endothelial responsiveness in healthy normocholesterolemic patients. Br J Pharmacol 2002;54:395-9.
20. John S, Schlaich M, Langenfeld M, et al. Increased bioavailability of nitric oxide after lipid-lowering therapy in hypercholesterolemic patients: a randomized, placebo-controlled, doubleblind study. Circulation 1998;98:211-6.
21. Kalinowski L, Dobrucki LW, Brovkovych V, Malinski T. Increased nitric oxide bioavailability in endothelial cells contributes to the pleiotropic effect of cerivastatin. Circulation 2002;105:933-8.
22. Wilkinson IB, Qasem A, McEniery CM, Webb DJ, Avolio AP, Cockcroft JR. Nitric oxide regulates local arterial distensibility in vivo. Circulation 2002;105:213-7.
23. Matsuo T, Iwade K, Hirata N, et al. Improvement of arterial stiffness by the antioxidant and anti-inflammatory effects of short-term statin therapy in patients with hypercholesterolemia. Heart Vessels 2005;20:8-12.
24. Shige H, Dart A, Nestel P. Simvastatin improves arterial compliance in the lower limb but not in the aorta. Athersoclesosis 2001;155:245-50.
25. Simon A, Gariepy J, Chironi G, Megnien JL, Levenson J. Intimamedia thickness: a new tool for diagnosis and treatment of cardiovascular risk. J Hypertens 2002;20:159-69.
26. Igarashi M, Takeda Y, Mori S, et al. Suppression of neointimal thickening by a newly developed HMG-CoA reductase inhibitor, BAYw6228, and its inhibitory effect on vascular smooth muscle cell growth. Br J Pharmacol 1997;120:1172-8.
27. Reid JA, Wolsley C, Lau LL, et al. The effect of pravastatin on intima media thickness of the carotid artery in patients with normal cholesterol. Eur J Vasc Endovasc Surg 2005;30:464-8.
28. Taylor AJ, Kent SM, Flaherty PJ, et al. A randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness (ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol ). Circulation 2002;106:2055-60.
29. Kawasaki T, Sasayama S, Yagi S, Asakawa T, Kirai T. Non-invasive assessment of the age related changes in stiffness of major branches of the human arteries. Cardiovasc Res 1987;21:678-87.